Supplementary Table from Development of Highly Effective Anti-Mesothelin Hyp218 Chimeric Antigen Receptor T Cells with Increased Tumor Infiltration and Persistence for Treating Solid Tumors | AMiner
Supplementary Table from Development of Highly Effective Anti-Mesothelin Hyp218 Chimeric Antigen Receptor T Cells with Increased Tumor Infiltration and Persistence for Treating Solid Tumors
Supplementary Table from Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors
原文链接
分享
引用
